Randomized in error in pragmatic clinical trials
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study addresses selection bias in pragmatic trials caused by errors in randomization. Bayesian methods effectively identify these errors and estimate true intervention effects, ensuring reliable clinical trial results.
Area Of Science
- Clinical Trials
- Biostatistics
- Health Informatics
Background
- Pragmatic trials integrating electronic health records and patient-reported data face selection bias from differential post-randomization exclusion of "randomized-in-error" participants.
- Incomplete pre-randomization data can lead to participants being deemed ineligible after randomization, particularly in the intervention arm, complicating analysis and validity.
Purpose Of The Study
- To develop a statistical approach to mitigate selection bias in pragmatic trials arising from differential post-randomization exclusion.
- To accurately estimate the average treatment effect among participants not randomized in error.
Main Methods
- A Bayesian model was developed within the potential outcomes framework to simultaneously identify "randomized-in-error" status and estimate the average treatment effect.
- Simulation studies evaluated the model's performance with 5%-15% randomization error rates, considering both measured and unmeasured outcomes for erroneous participants.
Main Results
- The proposed Bayesian model demonstrated satisfactory performance, yielding low bias (<1%) and high coverage (approx. 95%) for estimated average treatment effects.
- Alternative methods, such as intention-to-treat and covariate-adjusted estimators, exhibited notable biases and lower coverage in simulations.
Conclusions
- Differential exclusion post-randomization is a significant source of selection bias in pragmatic clinical trials.
- Bayesian methods offer a robust solution for identifying "randomized-in-error" participants and estimating intervention effects accurately, enhancing the reliability of trial findings.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
The most basic experimental design involves two groups: the experimental group and the control group. The two groups are designed to be the same except for one difference— experimental manipulation. The experimental group gets the experimental manipulation—that is, the treatment or variable being tested—and the control group does not. Since experimental manipulation is the only difference between the experimental and control groups, we can be sure that any differences between...
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Random or indeterminate errors originate from various uncontrollable variables, such as variations in environmental conditions, instrument imperfections, or the inherent variability of the phenomena being measured. Usually, these errors cannot be predicted, estimated, or characterized because their direction and magnitude often vary in magnitude and direction even during consecutive measurements. As a result, they are difficult to eliminate. However, the aggregate effect of these errors can be...